Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma
Phase 2 Study of Postoperative Three-dimensional Conformal Radiation Therapy/Intensive Modulated Radiation Therapy in Hepatocellular Carcinoma: a Single Center Prospective Study
Sponsor: Chinese Academy of Medical Sciences
A NA clinical study on Hepatocellular Cancer, this trial is completed. The trial is conducted by Chinese Academy of Medical Sciences and has accumulated 8 data snapshots since 2008. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Oct 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed · Phase: PHASE2 → NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting PHASE2
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese Academy of Medical Sciences
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Beijing, China